>From: "Technotranscendence" <email@example.com>
>LIFE EXTENSION UPDATE EXCLUSIVE: Crosslink-breaking drug ALT-711
>to be tested for hypertension
>ALT-711 is one of a new class of compounds called advanced
>glycosylation endproduct crosslink breakers. These drugs have the
>ability to break crosslinks caused by glycosylation, which is the
>binding of sugar to protein molecules. The resultant crosslinkage
>destroys the elasticity of tissue over time, leading to a loss of
>function. Glycosylation-induced damage occurs more frequently with
>age and with diabetes. Crosslinkage in the vacular system creates
>hardening of the arteries, or arteriosclerosis. When blood vessels
>cannot expand, blood pressure becomes elevated.
This is fascinating, this is right out of Linda Nagata's "Tech
Heaven". Anybody have her E-mail address.
Only 199 more vials to the complete life extension protocol....
Extropy Institute, www.extropy.org
National Rifle Association, www.nra.org, 1.800.672.3888
SBC/Ameritech Data Center Chicago, IL, Local 134 I.B.E.W
This archive was generated by hypermail 2b30 : Fri Oct 12 2001 - 14:39:48 MDT